Skip to main content

Key Product Details

Species Reactivity

Bovine

Applications

ELISA, Flow Cytometry, Immunoprecipitation

Label

FITC (Excitation = 495 nm, Emission = 519 nm)

Antibody Source

Monoclonal Mouse IgG2A Clone # IL-A73

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Purified bovine IgG2

Specificity

Mouse anti Bovine IgG2, clone IL-A73, is a monoclonal antibody specific for bovine IgG2 and does not recognize other bovine immunoglobulin classes.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2A

Applications for Mouse anti-Bovine IgG2 Heavy Chain Secondary Antibody (IL-A73) [FITC]

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.

Flow Cytometry

Optimal dilutions of this antibody should be experimentally determined.

Immunoprecipitation

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: IgG2 Heavy Chain

Additional IgG2 Heavy Chain Products

Product Documents for Mouse anti-Bovine IgG2 Heavy Chain Secondary Antibody (IL-A73) [FITC]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Mouse anti-Bovine IgG2 Heavy Chain Secondary Antibody (IL-A73) [FITC]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Secondary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...